RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Periodontal Atrophy
Accession: DOID:9005858
browse the term
Definition: Degradation or wasting of the PERIODONTIUM tissues that may involve the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, or the PERIODONTAL LIGAMENT.
Synonyms: exact_synonym: Atrophy of Periodontium; Gingivo Osseous Atrophy; Gingivo-Osseous Atrophies; Periodontal Atrophies; Periodontium Atrophies; Periodontium Atrophy
primary_id: MESH:D055093
G
VEGFA
vascular endothelial growth factor A
ISO
protein:decreased expression:maxilla:
RGD
PMID:22716278
RGD:7421608
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACP5
acid phosphatase 5, tartrate resistant
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
G
AGTR1
angiotensin II receptor type 1
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AGTR2
angiotensin II receptor type 2
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr X:116,170,744...116,174,974
Ensembl chr X:116,170,744...116,174,974
G
ALPL
alkaline phosphatase, biomineralization associated
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism associated with hypertension, periodontal disease
CTD RGD
PMID:20630305 PMID:33364953
RGD:329956421
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
G
CCR2
C-C motif chemokine receptor 2
ISO
associated with Periodontitis;
RGD
PMID:21241302
RGD:8661687
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CTSK
cathepsin K
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
G
CXCL1
C-X-C motif chemokine ligand 1
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
IL10
interleukin 10
treatment
ISO
associated with Diabetes Mellitus, Experimental associated with periodontal disease
RGD
PMID:26270535 PMID:33364953
RGD:11049527 , RGD:329956421
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1B
interleukin 1 beta
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGAV
integrin subunit alpha V
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
G
MMP2
matrix metallopeptidase 2
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
OSCAR
osteoclast associated Ig-like receptor
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr19:54,094,668...54,100,803
Ensembl chr19:54,094,668...54,102,692
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:14630900
RGD:10413909
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
associated with hypertension, periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
TNF
tumor necrosis factor
treatment
ISO
associated with Diabetes Mellitus, Experimental associated with periodontal disease
RGD
PMID:26270535 PMID:33364953
RGD:11049527 , RGD:329956421
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF11A
TNF receptor superfamily member 11a
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr18:62,325,310...62,391,288
Ensembl chr18:62,325,287...62,391,288
G
TNFRSF11B
TNF receptor superfamily member 11b
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFSF11
TNF superfamily member 11
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism associated with periodontal disease
CTD RGD
PMID:19249596 PMID:33364953
RGD:329956421
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
G
VTN
vitronectin
treatment
ISO
associated with periodontal disease
RGD
PMID:33364953
RGD:329956421
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all